-
公开(公告)号：US11202873B2
公开(公告)日：2021-12-21
申请号：US16704530
申请日：2019-12-05
Applicant: Mallinckrodt Pharmaceuticals Ireland Limited
Inventor： Jaron M. Acker , John C. Falligant , Jeff Milsap , Robin Roehl , Jeffrey Schmidt , Craig R. Tolmie
Abstract: Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system. The therapeutic gas delivery system controller of the system includes a processor that executes an algorithm to calculate the run-time-to-empty from the data received from the gas pressure sensor, temperature sensor, flow controller and flow sensor, and directs the result to the display.
-
公开(公告)号：US11141549B2
公开(公告)日：2021-10-12
申请号：US15010999
申请日：2016-01-29
Applicant: Mallinckrodt Pharmaceuticals Ireland Limited
Inventor： Craig R. Tolmie , Jeff Milsap , Jaron M. Acker
Abstract: Described are systems and methods for compensating long term sensitivity drift of catalytic type electrochemical gas sensors used in systems for delivering therapeutic nitric oxide (NO) gas to a patient by compensating for drift that may be specific to the sensors atypical use in systems for delivering therapeutic nitric oxide gas to a patient. In at least some instances, the long term sensitivity drift of catalytic type electrochemical gas sensors can be addressed using calibration schedules, which can factor in the absolute change in set dose of NO being delivered to the patient that can drive one or more baseline calibrations. The calibration schedules can be used reduce the amount of times the sensor goes offline. Systems and methods described may factor in in actions occurring at the delivery system and/or aspects of the surrounding environment, prior to performing a baseline calibration, and may postpone the calibration and/or rejected using the sensor's output for the calibration.
-
公开(公告)号：US20240316300A1
公开(公告)日：2024-09-26
申请号：US18732187
申请日：2024-06-03
Applicant: Mallinckrodt Pharmaceuticals Ireland Limited
Inventor： Jaron M. Acker , John C. Falligant , Jeff Milsap , Robin Roehl , Jeffrey Schmidt , Craig R. Tolmie
CPC classification number: A61M16/0051 , A61M16/024 , A61M16/1005 , A61M16/12 , A61M16/122 , A61M16/125 , A61M16/201 , A61M16/202 , A61M16/204 , B63C11/02 , G01F22/02 , A61M2016/0027 , A61M2016/0039 , A61M16/085 , A61M2016/102 , A61M16/208 , A61M2202/0275 , A61M2205/14 , A61M2205/16 , A61M2205/17 , A61M2205/3331 , A61M2205/3334 , A61M2205/3368 , A61M2205/3379 , A61M2205/50 , A61M2205/502 , A61M2205/52 , A61M2205/60 , A61M2205/6018 , A61M2205/6072 , A61M2205/8206 , F17C2250/00
Abstract: Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system. The therapeutic gas delivery system controller of the system includes a processor that executes an algorithm to calculate the run-time-to-empty from the data received from the gas pressure sensor, temperature sensor, flow controller and flow sensor, and directs the result to the display.
-
公开(公告)号：US20220168520A1
公开(公告)日：2022-06-02
申请号：US17674198
申请日：2022-02-17
Applicant: Mallinckrodt Pharmaceuticals Ireland Limited
Inventor： Jaron M. Acker , Craig R. Tolmie , Robin Roehl , Jeffrey Schmidt , Jeff Milsap
Abstract: Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system. The therapeutic gas delivery system controller of the system includes a processor that executes an algorithm to calculate the run-time-to-empty from the data received from the gas pressure sensor, temperature sensor, flow controller and flow sensor, and directs the result to the display.
-
公开(公告)号：US20220072247A1
公开(公告)日：2022-03-10
申请号：US17525349
申请日：2021-11-12
Applicant: Mallinckrodt Pharmaceuticals Ireland Limited
Inventor： Jaron M. Acker , John C. Falligant , Jeff Milsap , Robin Roehl , Jeffrey Schmidt , Craig R. Tolmie
Abstract: Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system. The therapeutic gas delivery system controller of the system includes a processor that executes an algorithm to calculate the run-time-to-empty from the data received from the gas pressure sensor, temperature sensor, flow controller and flow sensor, and directs the result to the display.
-
Patent Agency Ranking
公开(公告)号：US11090454B2
公开(公告)日：2021-08-17
申请号：US16825848
申请日：2020-03-20
Applicant: Mallinckrodt Pharmaceuticals Ireland Limited
Inventor： Jaron M. Acker , Craig R. Tolmie , Robin Roehl , Jeffrey Schmidt , Jeff Milsap
Abstract: Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system. The therapeutic gas delivery system controller of the system includes a processor that executes an algorithm to calculate the run-time-to-empty from the data received from the gas pressure sensor, temperature sensor, flow controller and flow sensor, and directs the result to the display.
-
公开(公告)号：US12226572B2
公开(公告)日：2025-02-18
申请号：US17984893
申请日：2022-11-10
Applicant: Mallinckrodt Pharmaceuticals Ireland Limited
Inventor： Jaron M. Acker , Jeff Milsap , Robin Roehl , Jeffrey Schmidt , Craig R. Tolmie
Abstract: Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system. The therapeutic gas delivery system controller of the system includes a processor that executes an algorithm to calculate the run-time-to-empty from the data received from the gas pressure sensor, temperature sensor, flow controller and flow sensor, and directs the result to the display.
-
公开(公告)号：US11998689B2
公开(公告)日：2024-06-04
申请号：US17525349
申请日：2021-11-12
Applicant: Mallinckrodt Pharmaceuticals Ireland Limited
Inventor： Jaron M. Acker , John C. Falligant , Jeff Milsap , Robin Roehl , Jeffrey Schmidt , Craig R. Tolmie
CPC classification number: A61M16/0051 , A61M16/024 , A61M16/1005 , A61M16/12 , A61M16/122 , A61M16/125 , A61M16/201 , A61M16/202 , A61M16/204 , B63C11/02 , G01F22/02 , A61M2016/0027 , A61M2016/0039 , A61M16/085 , A61M2016/102 , A61M16/208 , A61M2202/0275 , A61M2205/14 , A61M2205/16 , A61M2205/17 , A61M2205/3331 , A61M2205/3334 , A61M2205/3368 , A61M2205/3379 , A61M2205/50 , A61M2205/502 , A61M2205/52 , A61M2205/60 , A61M2205/6018 , A61M2205/6072 , A61M2205/8206 , F17C2250/00
Abstract: Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system. The therapeutic gas delivery system controller of the system includes a processor that executes an algorithm to calculate the run-time-to-empty from the data received from the gas pressure sensor, temperature sensor, flow controller and flow sensor, and directs the result to the display.
-
公开(公告)号：US20230270960A1
公开(公告)日：2023-08-31
申请号：US18109510
申请日：2023-02-14
Applicant: Mallinckrodt Pharmaceuticals Ireland Limited
Inventor： Jaron M. Acker , Jeff Milsap , Robin Roehl , Jeffrey Schmidt , Craig R. Tolmie
CPC classification number: A61M16/0051 , B63C11/02 , G01F22/02 , A61M16/204 , A61M16/024 , A61M16/12 , A61M16/1005 , A61M16/122 , A61M16/125 , A61M16/201 , A61M16/202 , A61M16/208 , A61M2205/6072 , A61M16/085
Abstract: A therapeutic gas delivery system with at least one gas supply subsystem is disclosed. The at least one gas supply subsystem may include a gas source coupling configured to receive a therapeutic gas source and form a fluid flow connection with the therapeutic gas source, a therapeutic gas delivery system controller, and one or more display(s) configured to be in communication over a communication path with the therapeutic gas delivery system controller. The display may be configured to display a graphical, illustrative, or numerical indicator of one or more flow or system parameters.
-
公开(公告)号：US20230073254A1
公开(公告)日：2023-03-09
申请号：US17984893
申请日：2022-11-10
Applicant: Mallinckrodt Pharmaceuticals Ireland Limited
Inventor： Jaron M. Acker , Jeff Milsap , Robin Roehl , Jeffrey Schmidt , Craig R. Tolmie
Abstract: Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system. The therapeutic gas delivery system controller of the system includes a processor that executes an algorithm to calculate the run-time-to-empty from the data received from the gas pressure sensor, temperature sensor, flow controller and flow sensor, and directs the result to the display.
-
-
-
-
-
-
-
-
-
Search Results
12
records
(took 0.019 seconds)
